Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BVCF Management is a leading venture capital/private equity firm founded in 2005 as one of the first in China focused exclusively on life sciences and healthcare. It has invested in nearly 50 innovative Chinese healthcare and biotech companies across all stages from early R&D to commercialization. Its investments have supported multiple successful IPOs and clinical advancements by its portfolio firms[1][2][5].
The fund’s impact includes supporting pioneering therapies for major unmet needs such as hepatitis B virus infection and cancer through its investees like Drug Farm. Portfolio highlights include positive Phase 3 results for Oculis’ eye drops for diabetic macular edema and public listings of several investee firms such as DiaCarta and CARsgen Therapeutics[6][8].
The team comprises professionals with deep scientific expertise led by Dr. Zhi Yang.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BVCF Management.